Subgroup analysis of 14% of patients who progressed to ESKD showed a trend towards increased HF hospitalizations in ARNI.
← all excerpts
Breaking barriers: Neprilysin inhibition in chronic cardiorenal syndrome.
1
—
—
Subgroup analysis of 14% of patients who progressed to ESKD showed a trend towards increased HF hospitalizations in ARNI.